220 related articles for article (PubMed ID: 21046244)
1. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.
Wong RJ; Gish R; Frederick T; Bzowej N; Frenette C
Dig Dis Sci; 2011 Feb; 56(2):578-85. PubMed ID: 21046244
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Tansel A; Katz LH; El-Serag HB; Thrift AP; Parepally M; Shakhatreh MH; Kanwal F
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1207-1217.e4. PubMed ID: 28215616
[TBL] [Abstract][Full Text] [Related]
7. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
[TBL] [Abstract][Full Text] [Related]
8. Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Dakhoul L; Jones KR; Gawrieh S; Ghabril M; McShane C; Vuppalanchi R; Vilar-Gomez E; Nephew L; Chalasani N; Lammert C
Dig Dis Sci; 2019 Jun; 64(6):1705-1710. PubMed ID: 30617453
[TBL] [Abstract][Full Text] [Related]
9. Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
Sharma R; Verna EC; Simon TG; Söderling J; Hagström H; Green PHR; Ludvigsson JF
Am J Epidemiol; 2022 Jan; 191(2):298-319. PubMed ID: 33913487
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.
Ohira H; Abe K; Takahashi A; Zeniya M; Ichida T
J Gastroenterol; 2013 Jan; 48(1):109-14. PubMed ID: 22688407
[TBL] [Abstract][Full Text] [Related]
11. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis.
Watanabe T; Soga K; Hirono H; Hasegawa K; Shibasaki K; Kawai H; Aoyagi Y
World J Gastroenterol; 2009 Jan; 15(2):231-9. PubMed ID: 19132775
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
van Gerven NM; Verwer BJ; Witte BI; van Erpecum KJ; van Buuren HR; Maijers I; Visscher AP; Verschuren EC; van Hoek B; Coenraad MJ; Beuers UH; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Mulder CJ; van Nieuwkerk CM; Bouma G;
Scand J Gastroenterol; 2014 Oct; 49(10):1245-54. PubMed ID: 25123213
[TBL] [Abstract][Full Text] [Related]
13. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
[TBL] [Abstract][Full Text] [Related]
14. Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.
Schauer C; van Rijnsoever M; Gane E
J Viral Hepat; 2019 Dec; 26(12):1372-1376. PubMed ID: 31323163
[TBL] [Abstract][Full Text] [Related]
15. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
16. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
[TBL] [Abstract][Full Text] [Related]
17. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma associated with autoimmune hepatitis.
Nishiyama R; Kanai T; Abe J; Hara R; Watahiki Y; Sakaguchi T; Nakamura S
J Hepatobiliary Pancreat Surg; 2004; 11(3):215-9. PubMed ID: 15235898
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]